Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2013-01-31
2015-10-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
NCT05649514
Assessment of Sleep Disturbance in Alzheimer Disease
NCT00831298
Toward a Real-time Access to Sleepers' Mental Content
NCT05452733
Sleep-dependent Learning in Aging
NCT03840083
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
NCT03256539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients from Memento cohort.
Patients with mild cognitive impairment included in MEMENTO cohort.
These patients will have a 2 night polysomnography, a battery of neuropsychological tests, a virtual reality test, and a subjective evaluation of sleep and somnolence at inclusion (Month 0) and Month 12.
2 night polysomnography
Polysomnography
battery of neuropsychological tests
virtual reality test
subjective evaluation of sleep and somnolence
Patients with memory disorders
Patients with mild cognitive impairment not included in MEMENTO cohort. For these patients a virtual reality test, and a subjective evaluation of sleep and somnolence will be performed at Inclusion (Month 0)
virtual reality test
subjective evaluation of sleep and somnolence
Healthy volunteers
Healthy volunteers matched in age, sex and educational level with patients. For these volunteers a virtual reality test, and a subjective evaluation of sleep and somnolence will be performed at Inclusion (Month 0)
virtual reality test
subjective evaluation of sleep and somnolence
control group
this group is composed with Healthy volunteers these volunteers will have a 2 night polysomnography, a battery of neuropsychological tests, a virtual reality test, and a subjective evaluation of sleep and somnolence at inclusion (Month 0) and Month 12.
2 night polysomnography
Polysomnography
battery of neuropsychological tests
virtual reality test
subjective evaluation of sleep and somnolence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2 night polysomnography
Polysomnography
battery of neuropsychological tests
virtual reality test
subjective evaluation of sleep and somnolence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* included in MEMENTO cohort within the last 3 months
* Clinical dementia rating scale ≤ 0,5 (not demented)
* Patients with mild cognitive impairment
* Visual and auditory acuity adequate for neuropsychological testing
* Having signed an informed consent
* Being affiliated to health insurance
* Aged 18 years and above
* First contact with Memory clinic within the last 3 months
* Clinical dementia rating scale ≤ 0,5 (not demented)
* Patients with mild cognitive impairment
* Visual and auditory acuity adequate for neuropsychological testing
* Having signed an informed consent
* Being affiliated to health insurance
* Aged 18 years and above
* Without evidence of psychopathology
* Volunteers matched in age, sex and educational level with patients
* Visual and auditory acuity adequate for neuropsychological testing
* Having signed an informed consent
* Being affiliated to health insurance
Exclusion Criteria
* Residence in skilled nursing facility
* Pregnant or breast feeding woman
* Alzheimer's disease caused by gene mutations
* Having a neurological disease
* History of stroke within the past three months
* Generalized anxiety (DSM-IV criteria)
* Schizophrenia history (DSM-IV criteria)
* Illiteracy, is unable to count or to read
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Philip, Pr
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2012/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.